Commitment issues: PrEP adherence in injecting drug users

Lancet HIV. 2017 Feb;4(2):e52-e53. doi: 10.1016/S2352-3018(16)30208-9. Epub 2016 Nov 18.

Authors

Kimberly Page¹, Oliver Bacon²

Affiliations

¹ Division of Epidemiology, Biostatistics and Preventive Medicine, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA. Electronic address: pagek@salud.unm.edu.
² Division of HIV, Infectious Disease, and Global Health, Department of Medicine, University of California San Francisco, San Francisco, CA, USA; San Francisco Department of Public Health, San Francisco, CA, USA.

PMID: 27866872
DOI: 10.1016/S2352-3018(16)30208-9

No abstract available

Publication types

Comment

MeSH terms

Anti-HIV Agents
Drug Users*
HIV Infections*
Humans
Medication Adherence
Pre-Exposure Prophylaxis

Substances

Anti-HIV Agents